Table 3.
Independent variables in the model | β | β’ | P | Model R 2 | β | β’ | P | Model R 2 |
---|---|---|---|---|---|---|---|---|
Participants with pre‐HbA1c ≥7.0% | Year 2020 (n = 2,095) | Year 2019 (n = 2,344) | ||||||
No clinic visit nor telemedicine | ||||||||
Telemedicine only | −0.136 | −0.074 | 0.001 | N/A | N/A | N/A | ||
Clinic visit only | −0.221 | −0.115 | <0.001 | −0.129 | −0.050 | 0.001 | ||
Telemedicine and clinic visit | −0.223 | −0.066 | <0.001 | N/A | N/A | N/A | ||
Pre‐HbA1c | 0.759 | 0.697 | <0.001 | 0.509 | 0.700 | 0.707 | <0.001 | 0.520 |
Pre‐BMI | 0.021 | 0.095 | <0.001 | 0.011 | 0.047 | 0.003 | ||
Age | 0.003 | 0.043 | 0.012 | 0.002 | 0.024 | 0.130 | ||
Male sex | −0.080 | −0.038 | 0.017 | −0.048 | −0.023 | 0.118 | ||
Type 2 diabetes | −0.045 | −0.013 | 0.423 | −0.100 | −0.029 | 0.052 |
β, regression coefficient; β’, standardized regression coefficient.
BMI, body mass index; HbA1c, glycated hemoglobin; N/A, not available.